ScholarLens Back to search
2009•Atherosclerosis SupplementsRequires access

Abstract: 535 CHOLESTEROL ABSORPTION AND SYNTHESIS MARKERS IN INDIVIDUALS WITH AND WITHOUT A CHD EVENT DURING PRAVASTATIN THERAPY: INSIGHTS FROM THE PROSPER TRIAL

Nirupa R. Matthan, N Restighini, Murray Robertson, Ian Ford, J. Shepherd, A. Lichtenstein, Ernst J. Schaefer

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Lathosterol, Cholestanol, Desmosterol, Campesterol, Internal medicine, Population, Cholesterol, Endocrinology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Abstract: 535 CHOLESTEROL ABSORPTION AND SYNTHESIS MARKERS IN INDIVIDUALS WITH AND WITHOUT A CHD EVENT DURING PRAVASTATIN THERAPY: INSIGHTS FROM THE PROSPER TRIAL — Research Paper | ScholarLens